DRY CUPPING IN CHILDREN WITH FUNCTIONAL CONSTIPATION: A RANDOMIZED OPEN LABEL CLINICAL TRIAL

Mahmoud Shahamat1,2, Babak Daneshfard3,4, Khadijeh-Sadat Najib1

  • 1Department of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Dry cupping therapy offers a comparable alternative to polyethylene glycol (PEG) laxatives for treating functional constipation in children. This Eastern manipulative therapy demonstrates effectiveness over a 4-week period.

Area of Science:

  • Pediatric Gastroenterology
  • Integrative Medicine
  • Clinical Trials

Background:

  • Pediatric functional constipation is a prevalent condition with significant community impact.
  • Eastern traditional manipulative therapies, like dry cupping, warrant investigation for pediatric conditions.

Purpose of the Study:

  • To evaluate the efficacy of dry cupping therapy compared to standard laxative treatment for functional constipation in children.
  • To assess the long-term effectiveness of dry cupping in pediatric patients.

Main Methods:

  • An open-label, randomized controlled trial involving 120 children (4-18 years) diagnosed with functional constipation.
  • Participants received either dry cupping therapy or Polyethylene Glycol (PEG) solution for 4 weeks.
  • Rome III criteria were used for evaluation at baseline and at 2, 4, 8, and 12 weeks.

Main Results:

  • Initially, PEG showed better results at 2 weeks.
  • By 4 weeks, dry cupping demonstrated significantly improved outcomes.
  • No significant differences in constipation rates were observed at 4 and 8 weeks between groups.

Conclusions:

  • Dry cupping therapy is as effective as standard laxative therapy for pediatric functional constipation.
  • Abdominal dry cupping presents a viable alternative treatment option for children with functional constipation.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
959
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
781
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
977
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
1.5K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
669
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
839